Earnings calendar/ICCC
IMMUCELL CORP /DE/ (ICCC)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter IMMUCELL CORP /DE/ has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$0.20
Est. $0.05 · +300.0%
Revenue
$7.2M
Est. $5.4M · +33.1%
Net income
$1.8M
As filed
EPS YoY
+233.3%
vs quarter ended 2025-06-30
Revenue YoY
+11.5%
vs quarter ended 2025-06-30
Next report
Nov 12, 2026
Scheduled · est. EPS $0.05
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$0.07
2025-09-30 through 2026-06-30
TTM revenue
$30.7M
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
75%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-13 | $0.20 | $7.2M | +233.3% | +11.5% | $0.05 | +300.0% |
| 2026-03-31Q1 FY2026 | 2026-05-14 | $0.21 | $10.4M | +31.2% | +28.4% | $0.05 | +320.0% |
| 2025-12-31Q4 FY2025 | 2026-03-30 | $-0.32 | $7.6M | -455.6% | -1.6% | $-0.01 | -3100.0% |
| 2025-09-30Q3 FY2025 | 2025-11-13 | $-0.02 | $5.5M | +77.8% | -8.4% | — | — |
| 2025-06-30Q2 FY2025 | 2025-08-14 | $0.06 | $6.4M | +130.0% | +17.8% | — | — |
| 2025-03-31Q1 FY2025 | 2025-05-14 | $0.16 | $8.1M | +366.7% | +11.2% | — | — |
| 2024-12-31Q4 FY2024 | 2025-03-28 | $0.09 | $7.8M | +160.0% | +52.1% | — | — |
| 2024-09-30Q3 FY2024 | 2024-11-13 | $-0.09 | $6.0M | +25.0% | +11.4% | — | — |
| 2024-06-30Q2 FY2024 | 2024-08-13 | $-0.20 | $5.5M | -11.1% | +54.9% | — | — |
| 2024-03-31Q1 FY2024 | 2024-05-14 | $-0.06 | $7.3M | +80.0% | +110.6% | — | — |
| 2023-12-31Q4 FY2023 | 2024-04-01 | $-0.15 | $5.1M | +31.8% | +30.3% | — | — |
| 2023-09-30Q3 FY2023 | 2023-11-13 | $-0.12 | $5.4M | -50.0% | +12.5% | — | — |
| 2023-06-30Q2 FY2023 | 2023-08-10 | $-0.18 | $3.5M | -100.0% | -8.5% | — | — |
| 2023-03-31Q1 FY2023 | 2023-05-11 | $-0.30 | $3.4M | -528.6% | -42.6% | — | — |
| 2022-12-31Q4 FY2022 | 2023-03-29 | $-0.22 | $3.9M | -2300.0% | -28.2% | — | — |
| 2022-09-30Q3 FY2022 | 2022-11-21 | $-0.08 | $4.8M | -500.0% | -6.9% | — | — |
| 2022-06-30Q2 FY2022 | 2022-08-11 | $-0.09 | $3.9M | -550.0% | -15.0% | — | — |
| 2022-03-31Q1 FY2022 | 2022-05-12 | $0.07 | $6.0M | +216.7% | +46.1% | $-0.10 | +170.0% |
| 2021-12-31Q4 FY2021 | 2022-03-30 | $0.01 | $5.4M | -66.7% | +45.4% | $-0.01 | +200.0% |
| 2021-09-30Q3 FY2021 | 2021-11-15 | $0.02 | $5.2M | +150.0% | +38.4% | $-0.06 | +133.3% |
| 2021-06-30Q2 FY2021 | 2021-08-12 | $0.02 | $4.5M | +118.2% | +53.1% | $-0.08 | +125.0% |
| 2021-03-31Q1 FY2021 | 2021-05-13 | $-0.06 | $4.1M | -200.0% | -16.4% | $0.05 | -220.0% |
| 2020-12-31Q4 FY2020 | 2021-03-30 | $0.03 | $3.7M | +150.0% | +3.1% | $0.01 | +175.2% |
| 2020-09-30Q3 FY2020 | 2020-11-12 | $-0.04 | $3.7M | +42.9% | +25.3% | $-0.08 | +50.0% |
| 2020-06-30Q2 FY2020 | 2020-08-12 | $-0.11 | $3.0M | -22.2% | +9.4% | $-0.10 | -10.0% |
| 2020-03-31Q1 FY2020 | 2020-05-13 | $-0.02 | $4.9M | -166.7% | +11.3% | — | — |
| 2019-12-31Q4 FY2019 | 2020-03-27 | $-0.06 | $3.6M | +66.7% | +23.7% | — | — |
| 2019-09-30Q3 FY2019 | 2019-11-12 | $-0.07 | $3.0M | -40.0% | +37.9% | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-12 | $-0.09 | $2.7M | +40.0% | -10.1% | — | — |
| 2019-03-31Q1 FY2019 | 2019-05-13 | $0.03 | $4.4M | +175.0% | +53.1% | — | — |
| 2018-12-31Q4 FY2018 | 2019-03-22 | $-0.18 | $2.9M | -500.0% | -6.2% | — | — |
| 2018-09-30Q3 FY2018 | 2018-11-13 | $-0.05 | $2.2M | +28.6% | +7.4% | — | — |
| 2018-06-30Q2 FY2018 | 2018-08-13 | $-0.15 | $3.0M | -200.0% | +72.3% | — | — |
| 2018-03-31Q1 FY2018 | 2018-05-14 | $-0.04 | $2.9M | -133.3% | -18.7% | — | — |
| 2017-12-31Q4 FY2017 | 2018-03-29 | $-0.03 | $3.1M | -400.0% | +41.5% | — | — |
| 2017-09-30Q3 FY2017 | 2017-11-13 | $-0.07 | $2.0M | -800.0% | +1.9% | — | — |
| 2017-06-30Q2 FY2017 | 2017-08-14 | $-0.05 | $1.7M | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2017-05-11 | $0.12 | $3.5M | — | — | — | — |
| 2016-12-31Q4 FY2016 | 2017-03-30 | $0.01 | $2.2M | — | — | — | — |
| 2016-09-30Q3 FY2016 | 2016-11-10 | $0.01 | $2.0M | — | — | — | — |
Need ICCC data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.